Delta-hexatoxin-Hv1b is a 42-residue peptide toxin encoded by an intronless gene in H. versuta . It shares 67% sequence identity with its paralog, Delta-hexatoxin-Hv1a (δ-ACTX-Hv1a), but exhibits distinct pharmacological properties, including reduced vertebrate toxicity and no insecticidal activity . The recombinant form (rHv1b) is produced via heterologous expression in yeast systems, enabling scalable production for research and therapeutic applications .
rHv1b is synthesized using a yeast (Saccharomyces cerevisiae) expression system, with protocols optimized for high yield and purity (>85% by SDS-PAGE) .
Expression Vector: pQE30 plasmid with E. coli SHuffle system .
Storage: Lyophilized at -80°C; reconstituted in deionized water with 50% glycerol for stability .
rHv1b modulates tetrodotoxin-sensitive (TTX-S) Naᵥ channels in vertebrates but lacks insecticidal activity .
Mechanistic Studies: Used to probe Naᵥ channel inactivation dynamics and subtype-specific interactions .
Safety Profile: Reduced vertebrate toxicity makes it safer for in vitro assays compared to Hv1a .
Biotechnological Utility: Serves as a template for engineering ion channel modulators with tailored selectivity .